Tata pharma mutual fund
WebMar 20, 2024 · Tata Mutual fund is part of the Tata group, one of India's largest and most respected industrial groups, renowned for its adherence to business ethics. The Group … WebApr 10, 2024 · This fund has Very High risk. low Low to Moderate Moderate Moderately High High Very High As per SEBI's Riskometer. Risk Details Portfolio of Mirae Asset Healthcare Fund - Regular Plan Asset Allocation Market Cap Weightage Portfolio Breakdown Peer Comparison Detailed Comparison Other details of Mirae Asset …
Tata pharma mutual fund
Did you know?
Web2 days ago · The direct plan of Tata Small Cap Fund has given a return of 44.79% while the regular plan has given a return of 42.17% in three years. The scheme tracks NIFTY Smallcap 250 Total Return Index ... Web22 hours ago · Also Read: Top Small Cap Schemes With Double-Digit Returns Templeton India Equity Income Fund. The direct plan of Templeton India Equity Income Fund has given a return of 36.72% while the regular ...
WebGet complete details on NAV, performance, scheme objective, regular and direct plan AUMs, Returns, Minimum SIP investment amount, benchmark, fund manager performance, Tata Mutual Fund contact ... Web2 days ago · Meeta Shetty, fund manager at Tata Mutual Fund manages Rs 12,363 crore under six funds such as Tata Digital India, Tata Focused Equity, Tata India Pharma & …
WebGet risk adjusted return analysis for Tata Nifty G-Sec Dec 2029 Index Fund. Understand and compare data with category ratios. Get various ratios like beta, alpha, sharpe ratio, treynor ratio etc ... WebThis is an Equity Sectoral/Thematic, Pharma fund with S&P BSE HEALTHCARE (TRI) as its benchmark. The risk level for this fund is categorized as Very High Risk. Total AUM ₹ 1,202.1 crores as of Mar 31, 2024 Age of Fund 4 years 4 months since Nov 30, 2024 Expense Ratio 2.15% as of Apr 06, 2024 Exit Load 1% upto 12 Months Ideal holding period
Web5 Year Return: 5.94% INVEST NOW Debt Fund PARTNERED BY Canara Robeco Savings Fund - Direct Plan (G) 3 Year Return: 5.43% 5 Year Return: 6.41% INVEST NOW Debt Fund PARTNERED BY Canara Robeco...
Web1 day ago · Tata Motors is expected to see a strong recovery in volume and significant improvement in free cash flow generation for the JLR business, which may have … new grandland ultimate specsWeb2 days ago · Meeta Shetty, fund manager at Tata Mutual Fund manages Rs 12,363 crore under six funds such as Tata Digital India, Tata Focused Equity, Tata India Pharma & Healthcare and Tata Large & Mid Cap. new grandland x 2022WebApr 3, 2024 · Tata India Pharma & Healthcare Fund (G) Invest online with ICICI Direct. Get Scheme Details, latest NAV, historical returns, top holdings, funds performance ratio, etc. … intervall hypoxie hyperoxie therapieWeb2 days ago · Meeta Shetty, fund manager at Tata Mutual Fund manages Rs 12,363 crore under six funds such as Tata Digital India, Tata Focused Equity, Tata India Pharma & … new grandma and grandpa giftsWebApr 14, 2024 · Pharmaceutical Mutual funds are funds which primarily invest in pharmaceutical stocks in India. Since these mutual funds invest money in a single theme/sector, they are categorized as High Risk equity investments. Last Updated: 09 Apr 2024, 04:35 a.m. (IST) Overview Short Term Returns Long Term Returns 52W range … intervall formel excelWebMar 29, 2024 · Tata India Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 December, 2015. The fund is managed by Meeta Shetty. The fund could potentially beat inflation in the long-run. Key parameters 1) Tata India Pharma & Healthcare Fund Direct Growth has a NAV of ₹ 17.7448 as on 29-03-2024. new grandland reviewsWebApr 6, 2024 · Get the latest information and complete track record of 'Tata India Pharma & HealthCare Fund - Direct Plan' schemes, returns, latest NAV and ratings from independent mutual fund research house. The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in eq. Tata India Pharma & HealthCare Fund ... new grandland ultimate 2022